Could stem cells rebuild lungs? first human trial begins for COPD
Disease control
Recruiting now
This early-stage study tests whether a new type of stem cell, called small mobile stem cells, can be safely delivered into the lungs of people with mild to moderate COPD. The trial involves 18 adults aged 39 to 69 and focuses on checking for side effects at three different doses.…
Phase: PHASE1 • Sponsor: SMSbiotech • Aim: Disease control
Last updated May 18, 2026 00:19 UTC